Aging Trajectories in Cancer Survivors

The Division of Cancer Control and Population Sciences (DCCPS) is interested in better understanding the short- and long-term effects of cancer and its treatment on aging trajectories during survivorship.

The NCI Cancer and Aging Fact Sheet provides a broad overview of the Division’s interests in cancer and aging and highlights initiatives aimed at addressing research needs.

Areas of Research Emphasis

  • Development of methodological and measurement approaches to identifying aging trajectories in survivorship
  • Identification of aging phenotypes in survivors and mechanisms underlying the emergent phenomena
  • Development of interventions to prevent, lessen,  or rehabilitate aging-related consequences of treatment
  • Use of population-based data and existing data resources to address survivorship and aging hypotheses
  • Use of patient-generated data to stratify risk, support decision-making, and optimize cancer  and aging outcomes in survivors
  • Measurement and surveillance of biological, behavioral, and psychosocial risk factors for multimorbidity in survivors
  • Inclusion of older adults in intervention and observational studies of survivorship
  • Influence of aging-related changes in body composition, energy balance, and health behaviors on cancer risk and outcomes

Funding Opportunity Announcements

Title Announcement # Expiration Date Contact

Research Infrastructure Development for Interdisciplinary Aging Studies


Notice of NCI's Participation in PAR-20-070

PAR-20-070 (R21/R33 – Clinical Trial Optional)



November 17, 2022

Winifred K. Rossi
National Institute on Aging

Jennifer Guida

NIH Research Project Grant PA-20-185 (Parent R01 Clinical Trial Not Allowed) May 08, 2023 Go to to explore NCI divisions and identify program contacts by interest.

Notice of Special Interest: Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes


January 08, 2024

Lisa Gallicchio, Ph.D.
240 276-5741

Modular R01s in Cancer Control and Population Sciences

More Information

PAR-21-190 (R01 Clinical Trial Optional) March 08, 2024

Scott Rogers

Selected Active NCI Grants

Last Updated
December 29, 2021